Skip to main content
Clinical Trials/CTRI/2017/08/009489
CTRI/2017/08/009489
Completed
未知

Evalaution of Biomarker of Endothelial Dysfunction and on Glycemic Control with Herbochromium Supplement in Type 2 Diabetes mellitus patients

Dr C Uday Kumar0 sites96 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Type 2 diabetes mellitus
Sponsor
Dr C Uday Kumar
Enrollment
96
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 22, 2015
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr C Uday Kumar

Eligibility Criteria

Inclusion Criteria

  • 1\.patients with fasting plasma glucose levels of 110\-126 mg/dL 2\.glycosylated haemoglobin (HbA1c) between 6\.5 % and 8% 3\. taking stable dose of anti\-diabetic treatment (metformin 1500\-2000 mg/day) for the past 8 weeks prior to the screening visit 4\. those who have endothelial dysfunction defined as \<\= 6% change in reflection index (RI) on post salbutamol challenge test

Exclusion Criteria

  • Patients with severe uncontrolled hyperglyceamia, uncontrolled hypertension, cardiac arrhythmia, impaired hepatic or renal function, history of malignancy or stroke, smoking, chronic alcoholism, any other serious disease requiring active treatment and treatment with any other herbal supplements, were excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials